not tagged
Triumvira
[]
our first clinical data from the her2- targeted tactic-2 phase 1/2 trial using tac-engineered t cells against #solidtumors shown safety &amp; early clinical activities. excited and proud to be a part of the team. #immunotherapy #tcell #biotwitter #esmo22
Translational Immunologist?  ? #Tcells #immunotherapy #immnunoengineering ? ? All tweets are my opinions only. RTs are not endorsements.